analysis

Indo US Bio-Tech Ltd.

NSE: INDOUS

BSE: 541304

Sector: Fast Moving Consumer Goods

Industry Group: Agricultural Food & other Products

Industry: Other Agricultural Products

64.99-2.9 (-4.29%)

23 Oct, 12:00 AM

Overview Analysis

Statements Technicals Forecast Peers Resources News

Summary Recommendation

A summary recommendation on the stock based on our classification and scoring techniques along with analyst recommendations.

StyleBox^TMWhat is StyleBox?

Value trap

The stock is low on quality and momentum and is a potential value trap.

Detail >

QVM scoreWhat is QVM score?

32.3 / 100

The stock has moderate QVM score relative to other stocks in the market. Neutral.

Analyst ratingWhat is Analyst rating?

No active sell-side coverage. Recommendations not available.

Technical indicatorsSee all >

13 %

Indo US Bio-Tech Ltd. on 1D timeframe is bullish for 3 out of 23 technical oscillators and moving averages.

Ratios and Statistics

A look at some key ratios and statistics for the stock. Change tabs to find the relevant ratios. Click on chart icon to view historical analysis of a particular ratio.

	2025 Oct 31	2025 Nov 30	2025 Dec 31	2026 Jan 31	2026 Feb 28	2026 Mar 31	2026 Apr 30	2026 May 31	2026 Jun 30	2026 Jul 31	2026 Aug 31	2026 Sept 30	2026 Oct 24
Multiples
P/E (TTM)	15.13	16.11	14.47	16.98	19.37	13.25	14.09	13.45	13.38	12.60	13.83	13.69	11.37
P/B (latest)	3.43	3.14	2.82	2.91	3.31	2.27	2.41	2.30	1.90	1.79	1.71	1.70	1.41
P/S (TTM)	2.45	2.30	2.06	2.14	2.44	1.67	1.77	1.69	1.59	1.50	1.41	1.39	1.16
CAPE (3Y)	25.22	25.48	22.88	23.59	26.89	18.41	19.57	18.68	14.00	13.18	12.41	12.29	10.21
CAPE (5Y)	28.44	28.73	25.80	26.60	30.33	20.76	22.07	21.06	16.43	15.47	14.82	14.67	12.19
P/E (1Y Forward)	-	-	-	-	-	-	-	-	-	-	-	-	-
P/S (1Y Forward)	-	-	-	-	-	-	-	-	-	-	-	-	-
Yields (%)
Book to Market	0.29	0.32	0.35	0.34	0.30	0.44	0.41	0.43	0.53	0.56	0.58	0.59	0.71
Earnings yield	6.61%	6.21%	6.91%	5.89%	5.16%	7.54%	7.10%	7.44%	7.47%	7.93%	7.23%	7.31%	8.79%
Operating CF yield	0.00%	-3.27%	-3.64%	-3.53%	-3.09%	-4.52%	-4.25%	-4.46%	-8.43%	-8.95%	-9.34%	-9.44%	-11.36%
FCFE yield	-0.13%	-0.13%	-0.14%	-0.14%	-0.12%	-0.18%	-0.17%	-0.18%	2.84%	3.02%	3.15%	3.18%	3.83%
FCFF yield	0.09%	0.09%	0.09%	0.09%	0.08%	0.11%	0.11%	0.11%	-7.55%	-7.94%	-8.24%	-8.30%	-9.68%

Historical Performance

Performance with respect to benchmark. Prices are adjusted for splits, bonus and rights issue.

Show dividend adjusted performance

NIFTY50

NIFTYFMCG

Add benchmark

Note: Prices are adjusted for splits, bonus and rights issue.

Showing:

Performance summary

	INDOUS	NIFTY50	NIFTYFMCG
	INDOUS	NIFTY50	NIFTYFMCG
Start Period	01 Jan 2021	01 Jan 2021	01 Jan 2021
End Period	23 Oct 2026	23 Oct 2026	23 Oct 2026
Cumulative Return	262.67%	61.22%	24.1%
CAGR	24.86%	8.58%	3.79%
Volatility (ann.)	66.89%	14.12%	14.03%
Max Drawdown	-82.72%	-17.23%	-35.63%
RoMaD	0.3%	0.5%	0.11%
Sharpe	0.61	0.39	0.06
Sortino	0.98	0.54	0.09
Sortino/√2	0.69	0.38	0.06

Style Analysis

Learn more about stock scores

Scores on value, momentum and quality parameters. Change tabs to compare across market, sector, industry.

Value score

91.2 / 100

↑

Indo US Bio-Tech Ltd. is undervalued relative to other stocks in the market

What is Value score?

Momentum score

7.0 / 100

↓

Indo US Bio-Tech Ltd. has low momentum relative to other stocks in the market

What is Momentum score?

Quality score

31.8 / 100

–

Indo US Bio-Tech Ltd. has moderate quality relative to other stocks in the market

What is Quality score?

QVM score

32.3 / 100

–

Indo US Bio-Tech Ltd. has moderate QVM score with respect to other stocks in the market

What is QVM score?

Scorecard

How to read Scorecard?

A comprehensive scorecard to compare Indo US Bio-Tech Ltd. on all metrics with other stocks. Access both rank and scores.

	Value	Market (All Stocks in NSE)	Sector (Fast Moving Consumer Goods)	Industry Group (Agricultural Food & other Products)	Industry (Other Agricultural Products)
Size and Listing
Days since Listing	3,088.00
Enterprise value	160 Cr
Market Cap	130 Cr
Liquidity
Avg daily turnover 1M	0 Cr
Avg daily volume 1M	7,765
Avg daily turnover 3M	0 Cr
Avg daily volume 3M	13,856
Bid Ask Spread	7.22%
Delivery Percentage	67.76%
Volume surge ratio	0.58
Ownership
DII Holding %	0.00%
QoQ change DII holding %	0.00%
FII Holding %	0.01%
QoQ change FII holding %	0.00%
QoQ change Gov holding %	0.00%
Promoter holding %	68.29%
QoQ change Promoter holding %	0.00%
Promoter pledged %	0.00%
Retail Holding %	26.60%
QoQ change Retail holding %	0.09%

Checklist

What is Checklist?

Analyse how the stock fares on some investment checklists created by legendary investors and gurus. Also, build your own custom checklist.

O'Shaughnessy Tiny Titans

Benjamin Graham's Value

Piotroski F-Score

Dreman contrarian value

Peter Lynch Growth/Value

O'Shaugnessy Value

Templeton Growth/Value

Warren Buffet’s Consistent Compounders

John Neff’s contrarian value

Richard Driehaus Momentum Strategy

O'Shaughnessy Tiny Titans

Created by the famous investor James O'Shaugnessy, this screen/checklist aims to find out small-cap stocks with significant growth potential. We look for companies with market capitalization between Rs 500 cr and Rs 1500 cr that are reasonable valued and are in the top 25 percentile momentum as measured by Momentum score.

20.0 / 100

Indo US Bio-Tech Ltd. passes 1 out of 5 of this checklist's rules

Hits

Market Cap is less than ₹1500 crore

Misses

Market Cap is greater than ₹500 crore

PS TTM is less than 1

One Year Rel Return is greater than 0%

Stock is in top 25.0 percentile, sorted by Price Momentum score in descending order

Frequently Asked Questions

What is the PB ratio of Indo US Bio-Tech Ltd.?

The Price-to-Book (PB) ratio of Indo US Bio-Tech Ltd. is 1.41. It compares the stock's market price to its book value per share.

What is the EV/EBITDA of Indo US Bio-Tech Ltd.?

The EV/EBITDA of Indo US Bio-Tech Ltd. is 9.72. This ratio is used to assess the overall value of a company relative to its earnings before interest, taxes, depreciation and amortisation.

What is the debt-to-equity ratio of Indo US Bio-Tech Ltd.?

The debt-to-equity (D/E) ratio of Indo US Bio-Tech Ltd. is 0.40. The interest coverage ratio stands at 4.40x, reflecting the company's capacity to service its debt from operating earnings. A lower D/E ratio generally indicates a more financially stable company with less leverage.

What is the promoter holding in Indo US Bio-Tech Ltd.?

Promoters hold 68.29% of Indo US Bio-Tech Ltd. shares as per the latest quarterly shareholding disclosure.

What is the operating profit margin of Indo US Bio-Tech Ltd.?

The operating profit margin of Indo US Bio-Tech Ltd. is 14.59%, reflecting how much profit the company earns from its core operations relative to revenue.

What is the net profit margin of Indo US Bio-Tech Ltd.?

The net profit margin of Indo US Bio-Tech Ltd. is 10.17%, indicating the percentage of revenue that remains as profit after all expenses.

What is the Sharpely score for Indo US Bio-Tech Ltd.?

On Sharpely's proprietary scoring system, Indo US Bio-Tech Ltd. has a Quality Score of 31.8/100, Value Score of 91/100 and Price Momentum Score of 6.5/100, with an overall QVM Score of 32.3/100. The quality rating is low, value is high and price momentum is low. Visit the Scorecard and Checklist sections on the Analysis tab for a full breakdown.